Tilray Brands Overview

  • Status
  • Public

  • Employees
  • 1,600

Employees

  • Stock Symbol
  • TLRY

Stock Symbol

  • Investments
  • 26

  • Share Price
  • $1.75
  • (As of Thursday Closing)

Tilray Brands General Information

Description

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Contact Information

Website
www.tilray.com
Formerly Known As
Tilray
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Distributors/Wholesale
Stock Exchange
NAS
Corporate Office
  • 265 Talbot Street West
  • Leamington, Ontario N8H 5L4
  • Canada

Tilray Brands Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tilray Brands Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.75 $1.77 $1.50 - $3.40 $1.45B 826M 35M -$0.44

Tilray Brands Financials Summary

In Thousands,
USD
TTM 29-Feb-2024 FY 2023 31-May-2023 FY 2022 31-May-2022 FY 2021 31-May-2021
EV 1,600,947 1,294,925 2,722,141 8,002,420
Revenue 743,248 627,124 628,372 513,085
EBITDA (161,523) (1,306,445) (258,138) (249,177)
Net Income (351,947) (1,452,656) (476,801) (367,421)
Total Assets 4,212,856 4,307,259 5,449,694 6,025,362
Total Debt 481,618 590,131 623,806 938,659
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tilray Brands Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tilray Brands‘s full profile, request access.

Request a free trial

Tilray Brands Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquir
Pharmaceuticals
Leamington, Canada
1,600 As of 2023
00000
000000000 00000

000000

reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Ex
00000000000000000000
Smiths Falls, Canada
0000 As of 0000
0000
000000000 0000

000000

t in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
0000000000000
New York, NY
0000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tilray Brands Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Canopy Growth Formerly Accelerator/Incubator backed Smiths Falls, Canada 0000 0000 000000000 0000
Curaleaf (Biotechnology) Formerly PE-Backed New York, NY 0000 00000 000000000 00000
Cronos Group (Pharmaceuticals) Corporation Toronto, Canada 000 00.000 000000&0
Trulieve Cannabis Corporate Backed or Acquired Quincy, FL 0000 00000 000000&0 00000
Verano Holdings Corporation Chicago, IL 0000 00000 0000 00000
You’re viewing 5 of 7 competitors. Get the full list »

Tilray Brands Patents

Tilray Brands Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220347152-A1 Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof Pending 29-Apr-2021 0000000000
CA-3217137-A1 Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof Pending 29-Apr-2021 000000000
CA-3159504-A1 Methods of administering cannabinoid to people diagnosed with hiv Pending 25-Oct-2019 0000000000
AU-2020369512-A1 Methods of administering cannabinoid to people diagnosed with hiv Pending 25-Oct-2019 0000000000
EP-4048256-A1 Methods of administering cannabinoid to people diagnosed with hiv Pending 25-Oct-2019 A61K31/352
To view Tilray Brands’s complete patent history, request access »

Tilray Brands Executive Team (23)

Name Title Board Seat Contact Info
Blair MacNeil President, Canada
Carl Merton Chief Financial Officer
Michael Kruteck Chief Financial Officer
Denise Faltischek Chief Strategy Officer and Head of International
Lloyd Brathwaite Chief Information Officer
You’re viewing 5 of 23 executive team members. Get the full list »

Tilray Brands Board Members (13)

Name Representing Role Since
000000000 00.00000 Tilray Brands Board Member 000 0000
00000 000000000 Tilray Brands Independent Director 000 0000
00000 00000 Self Chief Executive Officer & Chairman 000 0000
0000 00000 Self Board Member 000 0000
0000 0000000 Aphria Independent Director, Chair of the Audit Committee & Member of the Nominating and Corporate Governance Committee 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Tilray Brands Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tilray Brands Investments & Acquisitions (26)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Anheuser-Busch (Eight Beer & Beverage Brands) 02-Oct-2023 000000000 Beverages 00000 000
Widmer Brothers Brewing 29-Sep-2023 0000000000 Beverages 00000 000
Hiball 01-Sep-2023 0000000000 Beverages 00000 000
Shock Top 16-Aug-2023 0000000000 Beverages
10 Barrel Brewing 07-Aug-2023 Merger/Acquisition Beverages 00000 000
You’re viewing 5 of 26 investments and acquisitions. Get the full list »

Tilray Brands Subsidiaries (9)

Company Name Industry Location Founded
Truss Beverages Beverages Etobicoke, Canada 2018
Smith & Sinclair Food Products London, United Kingdom 0000
Montauk Brewing Company Beverages Montauk, NY 0000
Privateer Holdings PE/Buyout Seattle, WA 0000
Breckenridge Distillery Beverages Breckenridge, CO 0000
You’re viewing 5 of 9 subsidiaries. Get the full list »

Tilray Brands ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

35.83 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,191

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 921

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 452

Rank

00.00

Percentile

To view Tilray Brands’s complete esg history, request access »

Tilray Brands Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
MedMen Enterprises 18-Sep-2021 0000 00000 Completed
  • 2 buyers
Intelgenx Technologies 08-May-2018 PIPE 00.00 Completed
To view Tilray Brands’s complete exits history, request access »

Tilray Brands FAQs

  • Who is the founder of Tilray Brands?

    Brendan Kennedy is the founder of Tilray Brands.

  • Who is the CEO of Tilray Brands?

    Irwin Simon is the CEO of Tilray Brands.

  • Where is Tilray Brands headquartered?

    Tilray Brands is headquartered in Leamington, Canada.

  • What is the size of Tilray Brands?

    Tilray Brands has 1,600 total employees.

  • What industry is Tilray Brands in?

    Tilray Brands’s primary industry is Pharmaceuticals.

  • Is Tilray Brands a private or public company?

    Tilray Brands is a Public company.

  • What is Tilray Brands’s stock symbol?

    The ticker symbol for Tilray Brands is TLRY.

  • What is the current stock price of Tilray Brands?

    As of 13-Jun-2024 the stock price of Tilray Brands is $1.75.

  • What is the current market cap of Tilray Brands?

    The current market capitalization of Tilray Brands is $1.45B.

  • What is Tilray Brands’s current revenue?

    The trailing twelve month revenue for Tilray Brands is $743M.

  • Who are Tilray Brands’s competitors?

    Canopy Growth, Curaleaf (Biotechnology), Cronos Group (Pharmaceuticals), Trulieve Cannabis, and Verano Holdings are some of the 7 competitors of Tilray Brands.

  • What is Tilray Brands’s annual earnings per share (EPS)?

    Tilray Brands’s EPS for 12 months was -$0.44.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »